Market Closed -
Bombay S.E.
11:00:51 24/05/2024 BST
|
5-day change
|
1st Jan Change
|
88.09
INR
|
-4.07%
|
|
+4.97%
|
+35.52%
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,943
|
1,119
|
473.9
|
889
|
1,119
|
986.1
|
Enterprise Value (EV)
1 |
4,300
|
3,187
|
2,808
|
3,759
|
4,187
|
4,062
|
P/E ratio
|
10.5
x
|
8.37
x
|
4.15
x
|
6.55
x
|
14.2
x
|
7.77
x
|
Yield
|
0.76%
|
1.32%
|
3.11%
|
1.66%
|
1.32%
|
1.49%
|
Capitalization / Revenue
|
0.21
x
|
0.11
x
|
0.05
x
|
0.11
x
|
0.13
x
|
0.1
x
|
EV / Revenue
|
0.48
x
|
0.33
x
|
0.32
x
|
0.45
x
|
0.48
x
|
0.4
x
|
EV / EBITDA
|
6.13
x
|
4.48
x
|
4.13
x
|
6.03
x
|
6.79
x
|
5.81
x
|
EV / FCF
|
-13.9
x
|
9.51
x
|
-16.6
x
|
-6.59
x
|
-23.9
x
|
61.1
x
|
FCF Yield
|
-7.21%
|
10.5%
|
-6.04%
|
-15.2%
|
-4.19%
|
1.64%
|
Price to Book
|
1.25
x
|
0.67
x
|
0.27
x
|
0.47
x
|
0.57
x
|
0.48
x
|
Nbr of stocks (in thousands)
|
29,437
|
29,437
|
29,437
|
29,437
|
29,437
|
29,437
|
Reference price
2 |
66.00
|
38.00
|
16.10
|
30.20
|
38.00
|
33.50
|
Announcement Date
|
06/09/18
|
07/09/19
|
02/09/20
|
06/09/21
|
07/09/22
|
07/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
9,037
|
9,759
|
8,828
|
8,270
|
8,773
|
10,177
|
EBITDA
1 |
701.8
|
711
|
679.6
|
623.4
|
616.6
|
698.8
|
EBIT
1 |
635.7
|
638.1
|
601.4
|
544.7
|
531
|
608.6
|
Operating Margin
|
7.03%
|
6.54%
|
6.81%
|
6.59%
|
6.05%
|
5.98%
|
Earnings before Tax (EBT)
1 |
257.2
|
220.2
|
171.3
|
116.9
|
117
|
191.3
|
Net income
1 |
184.7
|
137.3
|
117.9
|
139.5
|
82.44
|
130.5
|
Net margin
|
2.04%
|
1.41%
|
1.34%
|
1.69%
|
0.94%
|
1.28%
|
EPS
2 |
6.276
|
4.538
|
3.880
|
4.610
|
2.675
|
4.309
|
Free Cash Flow
1 |
-310.2
|
335.2
|
-169.6
|
-570.7
|
-175.5
|
66.49
|
FCF margin
|
-3.43%
|
3.43%
|
-1.92%
|
-6.9%
|
-2%
|
0.65%
|
FCF Conversion (EBITDA)
|
-
|
47.14%
|
-
|
-
|
-
|
9.52%
|
FCF Conversion (Net income)
|
-
|
244.12%
|
-
|
-
|
-
|
50.93%
|
Dividend per Share
2 |
0.5000
|
0.5000
|
0.5000
|
0.5000
|
0.5000
|
0.5000
|
Announcement Date
|
06/09/18
|
07/09/19
|
02/09/20
|
06/09/21
|
07/09/22
|
07/09/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
2,357
|
2,069
|
2,334
|
2,870
|
3,068
|
3,076
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.359
x
|
2.91
x
|
3.434
x
|
4.604
x
|
4.975
x
|
4.402
x
|
Free Cash Flow
1 |
-310
|
335
|
-170
|
-571
|
-176
|
66.5
|
ROE (net income / shareholders' equity)
|
12.6%
|
8.52%
|
6.87%
|
7.64%
|
4.3%
|
6.5%
|
ROA (Net income/ Total Assets)
|
6.6%
|
6.28%
|
5.74%
|
4.92%
|
4.59%
|
5.26%
|
Assets
1 |
2,798
|
2,186
|
2,053
|
2,833
|
1,797
|
2,483
|
Book Value Per Share
2 |
52.80
|
56.70
|
59.90
|
64.10
|
66.30
|
70.10
|
Cash Flow per Share
2 |
3.030
|
1.280
|
3.690
|
2.710
|
0.2200
|
0.6100
|
Capex
1 |
117
|
85.4
|
18.8
|
153
|
87.7
|
73.3
|
Capex / Sales
|
1.3%
|
0.87%
|
0.21%
|
1.85%
|
1%
|
0.72%
|
Announcement Date
|
06/09/18
|
07/09/19
|
02/09/20
|
06/09/21
|
07/09/22
|
07/09/23
|
|
1st Jan change
|
Capi.
|
---|
| +35.52% | 31.22M | | +3.47% | 103B | | -8.74% | 61.43B | | +72.86% | 49.09B | | +15.48% | 38.46B | | +3.64% | 32.09B | | +13.29% | 20.39B | | +12.53% | 16.78B | | +15.34% | 14.76B | | +0.39% | 13.73B |
Other Commodity Chemicals
|